By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GeneMax Corp. 

1681 Chestnut Street, Suite 400

Vancouver  British Columbia  V6J 4M6  Canada
Phone: 866-872-0077 Fax:



Company News
GeneMax Corp. (GMXX.OB) Announces Completion Of US $1.4 Million Financing, And The Appointments Of Konstantine Sarafis As CEO And Dr. Glynn Wilson To Its Board Of Directors10/19/2005 5:12:43 PM
GeneMax Corp. (Formerly Eduverse.Com)'s (GMXX) TAP-1 Technology Corroborated In Models Of Skin Cancer10/19/2005 5:11:15 PM
GeneMax Corp. (Formerly Eduverse.Com) (GMXX) Licenses Technology From NIH For Vaccine For Smallpox10/19/2005 5:10:46 PM
GeneMax Corp. (GMXX.OB) Appoints Konstantine Sarafis As Chief Operating Officer10/19/2005 5:10:33 PM
GeneMax Corp. (Formerly Eduverse.Com) (GMXX) Airing On ABC News "Business Now" Program Rescheduled, Airing Changed To Sunday November 9, 200310/19/2005 5:10:25 PM
GeneMax Corp. (Formerly Eduverse.Com) (GMXX) Operational Update II - Advancing Towards Clinical Trials With TAP Cancer Vaccine10/19/2005 5:10:18 PM
GeneMax Corp. (Formerly Eduverse.Com) (GMXX) Announces New Directors And Formation Of Audit Committee10/19/2005 5:10:13 PM
GeneMax Corp. (Formerly Eduverse.Com) (GMXX) Announces License From University of British Columbia For Technology Designed To Identify Small Molecule Regulators Of Immune Response10/19/2005 5:10:04 PM
GeneMax Corp. (GMXX.OB) Announces Receipt Of Its Primary Vaccine Candidate For Oncology Applications10/19/2005 5:09:22 PM
GeneMax Corp. (GMXX.OB) Announces Publication Demonstrating The Efficacy Of A New Vector System In Treatment Of Models Of Lung Cancer10/19/2005 5:09:12 PM